 Arrowhead Pharmaceuticals, Inc. NASDAQ:ARWR Q4 2022 Earnings Conference Call November 28, 2022 4:30 PM ET Company Participants Vincent Anzalone - VP, IR Dr. Christopher Anzalone - President and CEO Dr. Javier San Martin - Chief Medical Officer Dr. James Hamilton - SVP, Discovery and Translational Medicine Ken Myszkowski - CFO Tracie Oliver - Chief Commercial Officer Patrick OBrien - Chief Operating Officer General Counsel Conference Call Participants Maury Raycroft - Jefferies Luca Issi - RBC Capital Markets Ellie Merle - UBS Joel Beatty - Robert W. Baird Edward Tenthoff - Piper Sandler Patrick Trucchio - H.C. 